Recent studies revealed the oncogenic potential of CREPT expression in multiple cancer types, including correlation with poor prognosis, induction of cell proliferation in vitro, and tumorigenesis in vivo [26,27,28]. The gene discussed is RPRD1B; the disease is cancer.